Elwood Capital Partners LP Takes $2.85 Million Position in Bath & Body Works, Inc. $BBWI

Key Points

• Elwood Capital Partners LP has purchased a new stake in Bath & Body Works, acquiring approximately 93,987 shares valued at $2.85 million, making it the 14th largest holding in its portfolio.
• Bath & Body Works recently announced a quarterly dividend of $0.20, reflecting a 2.6% dividend yield and showcasing its financial commitment to shareholders.
• The company reported earnings of $0.49 per share for the last quarter, exceeding expectations, while revenues were slightly below analyst estimates at $1.40 billion.

Elwood Capital Partners LP acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 93,987 shares of the company's stock, valued at approximately $2,850,000. Bath & Body Works makes up approximately 2.4% of Elwood Capital Partners LP's portfolio, making the stock its 14th largest holding.

Other hedge funds also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Bath & Body Works by 38.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after acquiring an additional 11,681 shares in the last quarter. Kovitz Investment Group Partners LLC bought a new position in Bath & Body Works during the fourth quarter worth about $258,000. Merit Financial Group LLC bought a new position in Bath & Body Works during the first quarter worth about $714,000. Nuveen Asset Management LLC grew its holdings in Bath & Body Works by 3.7% during the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after purchasing an additional 27,136 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in Bath & Body Works by 3,642.2% during the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after purchasing an additional 1,606,988 shares during the period. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Up 5.6%

Shares of BBWI stock opened at $31.0550 on Friday. The stock has a market cap of $6.57 billion, a P/E ratio of 8.28, a price-to-earnings-growth ratio of 0.99 and a beta of 1.54. The stock has a 50 day simple moving average of $30.30 and a 200 day simple moving average of $31.03. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.38 earnings per share. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's payout ratio is 21.33%.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of research analyst reports. Citigroup reduced their price target on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday. JPMorgan Chase & Co. lifted their price target on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. UBS Group boosted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. Morgan Stanley reduced their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Finally, The Goldman Sachs Group reduced their price objective on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Bath & Body Works currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.